X
09Oct

Caremark Round II: Beware Red Flags in Drug Development

Goodwin | | Return|
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/

Related

California Law Prohibits No-Rehire Provisions in Settlement Agreements

California law typically frowns on contracts that restrict a person's ability to engage in trade for...

Read More >

Revised Federal Rules Exclude Modern Perks and Benefits From the Regular Rate of Pay for Overtime Purposes

In a development sure to be welcomed by employers, the U.S. Department of Labor (DOL) issued revised...

Read More >

Cancelled Due to the Coronavirus: Maximizing Insurance Coverage for Event Cancellation Losses

Over the past several weeks, the COVID-19 coronavirus outbreak has shaken global markets and caused ...

Read More >

Antitrust Division Launches "Strike Force" to Combat Anticompetitive Crimes in Government Procurement

Last week, the U.S. Department of Justice ("DOJ") launched the Procurement Collusion Strike Force ("...

Read More >

RHS Amends Rules for Single Close Construction to Permanent Loans

The USDA’s Rural Housing Service (RHS) recently issued a final rule, pushing back from August 21, 2...

Read More >

Diversity Visa Lottery: Lawsuit over New Passport Rule

On September 25, 2019, we reminded clients that the Diversity Visa Lottery would be open from Octobe...

Read More >